Zhejiang Taimei Medical Technology Co. Ltd. held its first extraordinary general meeting of 2026 on February 14. All proposals set out in the meeting notice, including the adoption of the 2026 H Share Award Scheme, were approved by shareholders. The scheme aims to attract and retain qualified participants and recognize their contributions to the group's long-term growth and success.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhejiang Taimei Medical Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260215-12025436), on February 15, 2026, and is solely responsible for the information contained therein.